Quarterly desk notes exist so we do not rewrite “what is EU regulation” every month. These five were the Q2 pile.
2026 Q2 desk: SCCS season, China methods, MoCRA status board
Owner takeaway
1. SCCS opinions ≠ annex law.
2. China method announcements (No. 51 and friends) are lab work.
3. Mercury STSC date 1 July 2026 was the China cliff at quarter-end.
4. FDA Voices is a status board; listing is still the live US duty.
5. Do not start EU allergen artwork in Q3 if Q2 did not freeze the fragrance files.
Why this now
Close of 2026 Q2.
Who is affected
Owners who want one page, not twelve tabs.
What to do
Monitor
SCCS list; NMPA 公告通告; FDA MoCRA page.
Prepare
Allergen artwork and mercury specs before July.
Act
Anything still unplaced in the EU on old allergen art is now a Q3 incident.
Analysis
Owner takeaway stays free. Choose a plan on the membership page to read the full decision memo comfortably — paid plans also include Workbench and Verify credits.
Sources & related
Linked news
Track updates in Workbench, or upgrade for full Regulatory Details and follow-up tools.